Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine
about
ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)AllergoOncology - the impact of allergy in oncology: EAACI position paper.Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer.
P2860
Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine
@en
Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine.
@nl
type
label
Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine
@en
Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine.
@nl
prefLabel
Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine
@en
Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine.
@nl
P2860
P356
P1433
P1476
Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine
@en
P2093
Irene Fürdös
Josef Singer
P2860
P304
P356
10.3892/OL.2016.5001
P577
2016-08-11T00:00:00Z